OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
OM1 has raised $85.0M in total funding. The most recent round was Series D. The last funding was announced in July 2021.
OM1's investors include General Catalyst, Polaris Partners, Scale Venture Partners, 7wire Ventures, Breyer Capital.
OM1 is headquartered in Boston, United States.
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
OM1 is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OM1 — Funding & Investors." VCBacked, July 16, 2021, https://www.vcbacked.co/company/om1. Accessed August 14, 2026.
VCBacked. (2021). OM1 — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/om1
{{cite web |title=OM1 — Funding & Investors |url=https://www.vcbacked.co/company/om1 |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated